Millennium Biltmore Hotel
Los Angeles

Downtown Los Angeles, California


SYMPOSIUM INFORMATION

>General Information
>Faculty
>Program/Schedule
>Accreditation/CME Surveys
>Registration
>Hotel Reservations

 

Supported by:
GOOD SAMARITAN HOSPITAL
Los Angeles, CA

Officially Endorsed by:
THE HEART FAILURE SOCIETY OF AMERICA

Affiliated With:
INTERNATIONAL ACADEMY OF CARDIOLOGY

Related Conferences:


22nd Annual

Heart Failure 2018
Update on Diagnosis and Therapy
April 21, 2018

FACULTY

PROGRAM DIRECTOR

Uri Elkayam, MD, FACC
Professor of Medicine
Division of Cardiology
University of Southern California
Los Angeles, CA

PROGRAM CO-DIRECTOR

Anil K. Bhandari, MD, FACC
Director, Electrophysiology
Director, EPS Fellowship Program
Chair, CME Program
Good Samaritan Hospital
Associate Clinical Professor of Medicine
University of Southern California
Los Angeles, CA

INVITED SPEAKERS

Inder Anand, MD, PhD
Professor of Medicine
University of Minnesota Medical School
VA Medical Centers
Minneapolis, MN and San Diego, CA

Jay N. Cohn, MD
Professor of Medicine
Director, Rasmussen Center for Cardiovascular Disease Prevention
Cardiovascular Division
University of Minnesota Medical School
Minneapolis, MN

Christina Economides, MD, MM, FSCAI
Director, Women’s Cardiovascular Health Program
Good Samaritan Hospital
Los Angeles, CA

Gregg Fonarow, MD, FACC, FAHA, FHFSA
Eliot Corday Professor in Cardiovascular Medicine and Science
Director, Ahmanson – UCLA Cardiomyopathy Center
Co-Chief, UCLA Division of Cardiology
Co-Director, UCLA Preventative Cardiology Program
David Geffen School of Medicine, UCLA
Los Angeles, CA

Barry H. Greenberg, MD, FACC
Distinguished Professor of Medicine
Director, Advanced Heart Failure Treatment Program
UC San Diego
La Jolla, CA

Mazen Hanna, MD
Cleveland Clinic
Cleveland, OH

J. Thomas Heywood, MD
Medical Director,
Advanced Heart Failure and Mechanical Circulatory Support Program
Scripps Health
San Diego, CA

Saibal Kar, MD
Director, Interventional Cardiac Research
Interventional Cardiology Dept.
Cedars-Sinai Medical Center
Los Angeles, CA

Alan Maisel, MD, FACC
Professor of Cardiology, UCSD
La Jolla, CA

Ray V. Matthews, MD, FACC
Chief of Cardiovascular Medicine
Division of Cardiovascular Medicine
University of Southern California
Los Angeles, CA

Tien M.H. Ng, PharmD, FCCP, BCPS (AQ-C)
Associate Professor of Clinical Pharmacy and Medicine
Director, PGY2 Residency in Cardiology
School of Pharmacy & Keck School of Medicine
University of Southern California
Los Angeles, CA

Ronald Oudiz, MD
Professor of Medicine
The David Geffen School of Medicine at UCLA
Director, Liu Center for Pulmonary Hypertension
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Torrance, CA

Prediman K. Shah, MD, FACC
Shappell and Webb Family Chair in Clinical Cardiology
Director, Oppenheimer Atherosclerosis Research Center
Director, Atherosclerosis Prevention and Treatment Center
Cedars-Sinai Heart Institute
Professor of Medicine and Cardiology,
David Geffen School of Medicine, UCLA
Los Angeles, CA

Eric J. Velazquez, MD, FACP, FACC, FASE, FAHA
Professor of Medicine
Chief, Cardiovascular Imaging Section
Director, Cardiac Diagnostic Unit & Echocardiography Laboratories
Duke University Health System
Assistant Director, DCRI Clinical Trials
Duke Clinical Research Institute
Durham, NC

FACULTY DISCLOSURE
It is our policy to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. This information is used to plan future activities.